INCY· Biotech / Healthcare

Incyte Corporation

PER 14.2ROE 30.8%

Fundamentals

P/E Ratio14.21
P/B Ratio3.58
ROE30.8%
Operating Margin25.6%
Revenue Growth20.9%
EPS7.08
Dividend Yield—
Debt Ratio0.7%
Free Cash Flow$558.87M
Market Cap$20.11B

Source: Yahoo Finance · Synced daily · Dividend yield expressed as decimal percent.

Sector Position

neutral
Biotech / HealthcareScore 584 stocks in universe

Peers in sector

CIThe Cigna Group
PER 2.6ROE 16.3%
069620.KSDaewoong Pharmaceutical Co., Ltd
PER 6.5ROE 19.1%
AMGNAmgen Inc.
PER 24.3ROE 101.3%
EXELExelixis, Inc.
PER 17.5ROE 41.0%
DXCMDexCom, Inc.
PER 31.3ROE 35.6%

AI Insight

Incyte Corporation shows strong ROE 30.8%, attractive PER 14.2, high operating margin 25.6%, revenue growth 20.9% based on the latest fundamentals snapshot.